Cannabinoid activity curtails cocaine craving.
Piomelli
D
D
D000818:Animals; D002186:Cannabinoids / Q000819:agonists / Q000037:antagonists & inhibitors / Q000378:metabolism*; D003042:Cocaine / Q000378:metabolism* / Q000494:pharmacology; D019970:Cocaine-Related Disorders / Q000378:metabolism*; D004195:Disease Models, Animal; D013759:Dronabinol / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology; D006801:Humans; D010880:Piperidines / Q000378:metabolism / Q000494:pharmacology; D011720:Pyrazoles / Q000378:metabolism / Q000494:pharmacology; D043882:Receptors, Cannabinoid; D011955:Receptors, Drug / Q000037:antagonists & inhibitors / Q000378:metabolism*; D000077285:Rimonabant
D002186:Cannabinoids; D010880:Piperidines; D011720:Pyrazoles; D043882:Receptors, Cannabinoid; D011955:Receptors, Drug; D013759:Dronabinol; D003042:Cocaine; C062018:HU 211; D000077285:Rimonabant